{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:30:37Z","timestamp":1786995037061,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.nmd.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T03:31:46Z","timestamp":1537846306000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network"],"prefix":"10.1016","volume":"29","author":[{"given":"Shuko","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Horrocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-0153","authenticated-orcid":false,"given":"Ishaq","family":"Abu-Arafeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6777-0585","authenticated-orcid":false,"given":"Nuno","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"McWilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Naismith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elma","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Faisal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Choong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2018.09.005_bib0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2018.09.005_bib0002","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","volume":"5","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2018.09.005_bib0003","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jacc.2012.12.011","article-title":"Steroid therapy effectively delays Duchenne's cardiomyopathy","volume":"61","author":"Dec","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2018.09.005_bib0004","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2106\/JBJS.L.01577","article-title":"Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up","volume":"95","author":"Lebel","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.nmd.2018.09.005_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Biggar","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2018.09.005_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000447583","article-title":"Skeletal fragility in children with chronic disease","volume":"86","author":"Joseph","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.nmd.2018.09.005_bib0007","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nmd.2004.09.009","article-title":"Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention. Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004","volume":"15","author":"Quinlivan","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2018.09.005_bib0008","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nmd.2004.09.010","article-title":"Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004","volume":"15","author":"Biggar","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.nmd.2018.09.005_bib0009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.nmd.2010.07.272","article-title":"170th ENMC International Workshop: bone protection for corticosteroid treated Duchenne muscular dystrophy. 27-29 November 2009, Naarden, The Netherlands","volume":"20","author":"Quinlivan","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2018.09.005_bib0010","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.nmd.2012.07.010","article-title":"Fat Embolism Syndrome following minor trauma in Duchenne muscular dystrophy","volume":"22","author":"McAdam","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2018.09.005_bib0011","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01241398-200001000-00016","article-title":"Bone mineral density and fractures in boys with Duchenne muscular dystrophy","volume":"20","author":"Larson","year":"2000","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.nmd.2018.09.005_bib0012","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/165019701750300609","article-title":"Fracture risk in patients with muscular dystrophy and spinal muscular atrophy","volume":"33","author":"Vestergaard","year":"2001","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.nmd.2018.09.005_bib0013","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1469-8749.2002.tb00272.x","article-title":"Fracture prevalence in Duchenne muscular dystrophy","volume":"44","author":"McDonald","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2018.09.005_bib0014","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.091007","article-title":"The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy","volume":"25","author":"Henderson","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nmd.2018.09.005_bib0015","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.nmd.2012.06.354","article-title":"Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy","volume":"22","author":"Mayo","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2018.09.005_bib0016","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0883073816650034","article-title":"Fracture in Duchenne muscular dystrophy: natural history and vitamin d deficiency","volume":"31","author":"Perera","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2018.09.005_bib0017","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/000992280304200408","article-title":"Vertebral fractures in boys with Duchenne muscular dystrophy","volume":"42","author":"Bothwell","year":"2003","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.nmd.2018.09.005_bib0018","first-page":"276","article-title":"Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area","volume":"38","author":"Ahmed","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.nmd.2018.09.005_bib0019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1097-0258(19980228)17:4<407::AID-SIM742>3.0.CO;2-L","article-title":"British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood","volume":"17","author":"Cole","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.nmd.2018.09.005_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/adc.73.1.17","article-title":"Cross sectional stature and weight reference curves for the UK, 1990","volume":"73","author":"Freeman","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2018.09.005_bib0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions","volume":"17","author":"Bishop","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.nmd.2018.09.005_bib0022","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1359\/jbmr.040902","article-title":"Epidemiology of childhood fractures in Britain: a study using the general practice research database","volume":"19","author":"Cooper","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nmd.2018.09.005_bib0023","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","article-title":"Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy","volume":"68","author":"King","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2018.09.005_bib0024","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00198-016-3774-5","article-title":"The time to and determinants of first fractures in boys with Duchenne muscular dystrophy","volume":"28","author":"Ma","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nmd.2018.09.005_bib0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2016.11.078","article-title":"Long-term outcome of interdisciplinary management of patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment","volume":"182","author":"Wong","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2018.09.005_bib0026","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00415-009-5012-y","article-title":"Prednisone 10 days on\/10 days off in patients with Duchenne muscular dystrophy","volume":"256","author":"Straathof","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2018.09.005_bib0027","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/BPO.0000000000000817","article-title":"Vertebral fractures in Duchenne muscular dystrophy patients managed with deflazacort","volume":"38","author":"Singh","year":"2018","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.nmd.2018.09.005_bib0028","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1359\/jbmr.090202","article-title":"Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program","volume":"24","author":"Halton","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nmd.2018.09.005_bib0029","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/acr.20589","article-title":"Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study","volume":"64","author":"Rodd","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.nmd.2018.09.005_bib0030","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1210\/JC.2015-2176","article-title":"Incident vertebral fractures in children with leukemia during the four years following diagnosis","volume":"100","author":"Cummings","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nmd.2018.09.005_bib0031","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","article-title":"The management of osteoporosis in children","volume":"27","author":"Ward","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nmd.2018.09.005_bib0032","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1200\/JCO.2011.40.4830","article-title":"High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy","volume":"30","author":"Alos","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nmd.2018.09.005_bib0033","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/pbc.25942","article-title":"The spectrum of recovery from fracture-induced vertebral deformity in pediatric leukemia","volume":"63","author":"Dal Osto","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.nmd.2018.09.005_bib0034","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jocd.2015.10.002","article-title":"The radiology of vertebral fractures in childhood osteoporosis related to glucocorticoid administration","volume":"19","author":"Lentle","year":"2016","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.nmd.2018.09.005_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/archdischild-2015-308654","article-title":"Short stature and pubertal delay in Duchenne muscular dystrophy","volume":"101","author":"Wood","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2018.09.005_bib0036","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1440-1754.2009.01506.x","article-title":"Assessing the skeleton in children and adolescents with disabilities: avoiding pitfalls, maximising outcomes. A guide for the general paediatrician","volume":"45","author":"Zacharin","year":"2009","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.nmd.2018.09.005_bib0037","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/jcem.85.3.6451","article-title":"Influence of puberty on muscle area and cortical bone area of the forearm in boys and girls","volume":"85","author":"Schoenau","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nmd.2018.09.005_bib0038","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1152\/ajpendo.00445.2001","article-title":"Influence of puberty on muscle development at the forearm","volume":"283","author":"Neu","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nmd.2018.09.005_bib0039","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0035-1563696","article-title":"Testosterone treatment of pubertal delay in duchenne muscular dystrophy","volume":"46","author":"Wood","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2018.09.005_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JND-170280","article-title":"Outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD Global Database","volume":"4","author":"Koeks","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2018.09.005_bib0041","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.braindev.2016.04.001","article-title":"Long-term outcomes of steroid therapy for Duchenne muscular dystrophy in Japan","volume":"38","author":"Goto","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2018.09.005_bib0042","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.880170405","article-title":"Deflazacort in Duchenne dystrophy: study of long-term effect","volume":"17","author":"Angelini","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2018.09.005_bib0043","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00415-006-0212-1","article-title":"Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation","volume":"253","author":"Pradhan","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2018.09.005_bib0044","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617313160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617313160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:08:00Z","timestamp":1760774880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896617313160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0960896617313160"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2018.09.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}